ALTANA AG Takes Minority Equity Stake in GPC Biotech AG
"We are delighted to have ALTANA as a new strategic investor. This reflects ALTANA's strong support of GPC Biotech as well as its satisfaction with our ongoing alliances. ALTANA's substantial investment further solidifies GPC Biotech's already strong cash position", commented Bernd R. Seizinger, M.D., Ph.D., President and CEO of GPC Biotech.
"GPC Biotech belongs to the most interesting and sophisticated transatlantic biotech companies with locations in Germany and the US. GPC Biotech has proved itself in a reliable and competent partnership which builds the foundation for our entrance as strategic investor", said Dr. Hans-Joachim Lohrisch, member of the managing board of ALTANA AG.
Other news from the department business & finance
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.